Intravenous Vitamin C is a cancer killer the FDA still wants to ban

Vitamin C has a broad spectrum antioxidant function with the ability to protect cell structures and DNA from free radical damage. Vitamin C is remarkably safe even in enormously high doses. Compared to commonly used prescription drugs, side effects are virtually nonexistent.

No matter how high the concentration, vitamin C does not harm healthy cells. Yet, through an array of enzymatic and metabolic reactions, vitamin C has an impressive ability to protect and treat and wide range of diseases, including cancer. When something is this effective at treating disease, the FDA will stop at nothing to prevent public access.

The benefits of long-term vitamin C consumption in excess of the U.S. government recommended daily allowance (RDA) are widely acknowledged and include reduced risks of cancer, cardiovascular disease, and cataracts.

Higher-than-RDA vitamin C intakes have been associated with increases in good HDL cholesterol, decreases in LDL cholesterol oxidation, decreased blood pressure and decreased cardiovascular mortality.